Since April 2012 and as of 4 June 2014, 815 cases of MERS-CoV infection have been reported by local health authorities worldwide, including 313 deaths.
The final report of the FLURISK project by the European Food Safety Authority (EFSA) proposes a risk assessment framework to rank animal influenza strains according to their potential to infect humans.
On 18 April 2014, the Hellenic Centre for Disease Control and Prevention (KEELPNO) announced a laboratory confirmed case of MERS-CoV infection in a 69 year old male patient.
The authors used a test-negative case control design to estimate the 2013/14 influenza vaccine effectiveness (VE) in patients seen with influenza-like illness as outpatients in Spain during December 2013-January 2014.
On 8 January 2014, Canada reported a fatal imported case of influenza A(H5N1) infection. This is the first confirmed human case of H5N1 in North America.
Without baseline human immunity to the emergent avian influenza A(H7N9) virus, neuraminidase inhibitors are vital for controlling viral replication in severe infections.
On 14 August 2013 highly pathogenic avian influenza (HPAI) was detected in poultry in Ostellato, Ferrara province, Emilia-Romagna, Italy. Influenza subtype A(H7N7) was confirmed.